Christopher J. Meade

BlackRock CLO Christopher Meade sold 18,095 shares for $19,942,340.13 on 2026-07-16; retains 14,059 non-derivative shares post-sale.

Christopher J. Meade, General Counsel and CLO, executed 2 separate sales totaling 18,095 shares for $19,942,340.13 at a blended average price of $1,102.09. This represents a 56.3% reduction in non-derivative holdings, from 32,154 to 14,059 shares. Notably, Meade's cross-ticker track record shows a 100.00% well-timed rate on his prior 12 sells, with negative average 90-day returns of -6.9%; his prior 5 sales at BLK specifically were all well-timed at the 90-day mark, ranging from -2.0% to -2.8% post-trade. The current stock price of $1,072.20 is 12.1% below the 52-week high of $1,219.94 and 2.8% below the transaction prices (blended $1,102.09), suggesting the sale occurred near elevated valuations relative to recent trading ranges.

BlackRock General Counsel Meade sold 18,000 shares for $18.8M on 2024-12-06, reducing holdings by 68.1%

Christopher J. Meade, BlackRock's General Counsel and CLO, executed 9 separate sales totaling 18,000 shares for $18,824,988.46 at blended average price $1,045.83 on 2024-12-06, reducing his holdings from 26,436 to 8,436 shares. His prior 3 sales at BLK all posted negative 90-day returns (ranging -1.5% to -5.8%), demonstrating a pattern of well-timed selling at this ticker: each sale preceded subsequent stock declines. The 90-day track record shows a 100.00% well-timed rate across his cross-ticker history. The magnitude of this divestiture—liquidating 68.1% of his position near the 52-week high of $1,053.84 (current price $1,042.87 is only 1.0% below the 52-week peak)—mirrors the consistent execution pattern observed in his prior BLK sales, continuing his track record of exiting positions before downward momentum.